Search Results 1851-1860 of 16713 for Epilepsy (Partial Onset)

  1. Medical Research & Education - Mayo Clinic News Network

    Neurologist Nick Gregg, M.D., and team developed a personalized approach to deep brain stimulation (DBS) that maps each patient's seizure network before ...

  2. Medical Research & Education - Mayo Clinic News Network

    Neurologist Nick Gregg, M.D., and team developed a personalized approach to deep brain stimulation (DBS) that maps each patient's seizure network before ...

  3. Medical Research & Education - Mayo Clinic News Network

    Gregory Worrell shares how technological innovation is transforming the future of epilepsy care. Latest stories. 'Zombie' cells spark inflammation in severe ...

  4. Medical Research & Education - Mayo Clinic News Network

    New study in Brain Communications finds personalized deep brain stimulation shows promise for drug-resistant epilepsy. Alison Satake. April 7, 2025.

  5. Medical Research & Education - Mayo Clinic News Network

    New study in Brain Communications finds personalized deep brain stimulation shows promise for drug-resistant epilepsy. Alison Satake. April 7, 2025.

  6. Medical Research & Education - Mayo Clinic News Network

    New study in Brain Communications finds personalized deep brain stimulation shows promise for drug-resistant epilepsy. Alison Satake. April 7, 2025.

  7. Medical Research & Education - Mayo Clinic News Network

    (VIDEO) When seizures don't stop: The battle against drug-resistant epilepsy ... epilepsy. News Releases. Mayo Clinic researchers lead transformative shift ...

  8. Medical Research & Education - Mayo Clinic News Network

    New study in Brain Communications finds personalized deep brain stimulation shows promise for drug-resistant epilepsy. Alison Satake. April 7, 2025.

  9. Neurology - Doctors - Mayo Clinic

    Epilepsy, Tonic-clonic seizure, Seizure , Absence seizure, Frontal lobe seizure, Febrile seizure, Angelman syndrome. Lily C. Wong ...

  10. Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170) - Mayo Clinic

    Has relapsed after autologous stem cell transplant (auto-SCT) or has failed to achieve a Complete Response or Partial Response within 60 days of auto-SCT.